HeXun Biosciences Co., Ltd.
Update：2026/11/10
Industries
Main Industry
Biotechnology
Main Product/Service
HeXun’s offerings include allogeneic mesenchymal‑stem‑cell drugs, contract development and manufacturing services (CDMO/CMO), sterile‑filling services, cell and derivative testing and consulting, and a laboratory information‑management system — supported
The content above was translated by Ai
Founded Year
2019
Unified Business No.
50924393
Status
Active
Number of Employees
46
Total Paid-in
Capital
521,340,000 (NT$)
Location of Company
Taiwan
, Taoyuan City
Exit Status
Emerging Stock Exchange(2023)、OTC listing(2026)
Company names, registration status, legal representatives, founding years, paid-in capital, registered addresses, and other details are sourced from business registration records maintained by Taiwan’s Administration of Commerce, Ministry of Economic Affairs. Exit status includes Emerging Stock Board listings, M&A, and IPOs. Information on overseas expansion is self-reported by startups.
Note 1: FINDIT compiles company information from public and other sources for reference and does not serve as a point of contact for the companies listed.
Note 2: Some company profiles and product/service descriptions are translated using AI and provided for reference only. In case of discrepancies or ambiguity, the original text prevails.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
HeXun Biosciences Co., Ltd., founded in 2019, is a biotechnology company dedicated to stem‑cell research and therapy, aiming to transform cutting‑edge cellular technologies into high‑quality medical solutions under its core philosophy “LIVE LONG, HEALTHY & HAPPY,” with the mission of improving global human health and well‑being.
The content above was translated by Ai
